Tag: NIH
-
NIH Funds Nanotech Tools for Cancer, Blood Clots
A bioengineering lab is receiving awards from National Institutes of Health to apply nanotechnology to treatments for breast cancer and diagnostics for deep vein blood clots.
-
Second Trial Approved for Cancer Pain Drug
The U.S. Food and Drug Administration approved a new clinical trial to test the efficacy and safety of an experimental drug designed to relieve stubborn chronic pain associated with cancer.
-
Organ Chips to be Studied on Space Station
A range of biological functions will be assessed with model organs on plastic chips in a series of experiments on the International Space Station.
-
Research, Medical Groups Join Science March
A collection of 25 organizations representing a range of medical research and practice disciplines announced their participation in the March for Science set for Saturday, 22 April.
-
NIH Funds Drug-Resistant Malaria Therapy Trial
An agency of National Institutes of Health is funding a clinical trial of a new malaria drug engineered to overcome resistance developed to earlier treatments.
-
Zika DNA Vaccine Begins Clinical Trial
A new clinical trial is underway testing a Zika vaccine that uses genetically-engineered DNA to generate an immune response against the disease.
-
Precision Medicine, “My Hope for the Future”
A meeting on Capitol Hill in Washington, D.C. today heard about one person’s struggle with cystic fibrosis and her hope for precision medicine to provide a cure.
-
Skin Health Data Collected by App Offered for Research
A smartphone app collecting images and data about moles on the skin of volunteers is now available to researchers for studies of cancer and other disorders.
-
Company, NC State Partner on Tissue Oxygen Patch
Profusa Inc. and a research center at North Carolina State University are developing a new device to monitor tissue oxygen levels in people with peripheral artery disease.
-
News Blackout Imposed on U.S. Science Agencies [Updated]
Multiple news services today are reporting that the Trump administration is ordering several U.S. government agencies conducting or funding scientific research to cease discussing its activities with the media or public officials.